Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Taisho Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11023
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, zosyn and palux, pabron, taisho kampo ichoyaku, others. It business segments include self-medication, prescription pharmaceutical, and overseas development. Taisho also sells macrolide antibiotic agent clarith. The company markets its products through distributors in Malaysia, the Philippines, Indonesia, Thailand, Hong Kong, Taiwan, Australia, the US, the UK, Vietnam and China. Taisho is headquartered in Tokyo, Japan.

Taisho Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Polyphor Enters into Research Agreement with Taisho Pharma 10
Taisho Pharma Enters into Distribution Agreement with Biofermin Pharma 11
Licensing Agreements 12
Taisho Pharma Enters into Licensing Agreement with Bayer Yakuhin 12
Asset Transactions 13
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 13
Acquisition 14
Taisho Pharma to Acquire Additional 7.06% Stake in Duoc Hau Giang Pharma 14
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 15
Taisho Pharma Acquires 24.5% stake in Duoc Hau Giang Pharma 16
Taisho Pharmaceutical Co Ltd – Key Competitors 17
Taisho Pharmaceutical Co Ltd – Key Employees 18
Taisho Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Polyphor Enters into Research Agreement with Taisho Pharma 10
Taisho Pharma Enters into Distribution Agreement with Biofermin Pharma 11
Taisho Pharma Enters into Licensing Agreement with Bayer Yakuhin 12
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 13
Taisho Pharma to Acquire Additional 7.06% Stake in Duoc Hau Giang Pharma 14
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 15
Taisho Pharma Acquires 24.5% stake in Duoc Hau Giang Pharma 16
Taisho Pharmaceutical Co Ltd, Key Competitors 17
Taisho Pharmaceutical Co Ltd, Key Employees 18
Taisho Pharmaceutical Co Ltd, Other Locations 19

List of Figures
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sanquin Blood Supply Foundation-医療機器分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Lonza Group Ltd (LONN)-製薬・医療分野:企業M&A・提携分析
    Summary Lonza Group Ltd (Lonza) is a biopharmaceutical company that manufactures and develops chemical and biological active pharmaceutical ingredients, and other products and services. The company offers active pharmaceutical ingredients, stem cell therapies, drinking water sanitizers, vitamin B co …
  • Pakistan Petroleum Limited (PPL)-石油・ガス分野:企業M&A・提携分析
    Summary Pakistan Petroleum Limited (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company produces crude oil, natural gas, natural gas liquids, liquefied petroleum gas and barytes. It operates producing fields in Sui, Kandhkot, A …
  • Novelis Inc:企業の戦略・SWOT・財務分析
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kansas City Power & Light Co:発電所・企業SWOT分析
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Wintac Ltd (524758):製薬・医療:M&Aディール及び事業提携情報
    Summary Wintac Ltd (Wintac), formerly Recon Ltd is a manufacturer and marketer of sterile products. The company offers opthalmic products such as anti-glaucoma, anti-cholinergic, artificial tear, NSAID, steroids and combination, anti-infective, decongestant, anti allergic eye drops and nasal drop, a …
  • Minnkota Power Cooperative Inc:企業の戦略的SWOT分析
    Minnkota Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Stanbic IBTC Holdings Plc:企業の戦略・SWOT・財務情報
    Stanbic IBTC Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic IBTC Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Randstad Holding nv:企業の戦略・SWOT・財務分析
    Randstad Holding nv - Strategy, SWOT and Corporate Finance Report Summary Randstad Holding nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vishay Intertechnology Inc (VSH):企業の財務・戦略的SWOT分析
    Vishay Intertechnology Inc (VSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Natera Inc (NTRA):企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Prime Polymer Co Ltd:企業の戦略的SWOT分析
    Prime Polymer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Jamaica Public Service Co Ltd:企業の発電所・SWOT分析2018
    Jamaica Public Service Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • PT Kideco Jaya Agung:企業の戦略・SWOT・財務情報
    PT Kideco Jaya Agung - Strategy, SWOT and Corporate Finance Report Summary PT Kideco Jaya Agung - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • REVA Medical Inc (RVA):企業の財務・戦略的SWOT分析
    Summary REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It off …
  • Apollo Commercial Real Estate Finance, Inc.:企業のM&A・事業提携・投資動向
    Apollo Commercial Real Estate Finance, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apollo Commercial Real Estate Finance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Public Power Corporation SA:発電所・企業SWOT分析
    Public Power Corporation SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Chrono Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Chrono Therapeutics Inc (CTI) is a personalized medicine manufacturer that provides programmable passive transdermal drug delivery products. The company provides smartstop, a programmable smoking cessation therapy that helps people to quit smoking and improve cessation outcomes. Its wearable …
  • Banco BBVA Argentina SA (BBAR3):企業の財務・戦略的SWOT分析
    Banco BBVA Argentina SA (BBAR3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆